October Prime Day: Tineco Lightens the Fall Routine
PARIS–(BUSINESS WIRE)–The back-to-school season is already in full swing, but who says it has to drain all your energy? For a cleaner home and an easier... Read more.
RIBOMIC Announces Positive Phase 2 Cohort 2 Results for Umedaptanib Pegol in Achondroplasia, Demonstrating an Increase in the Annualized Growth Rate of up to +5.0 cm/year with Biweekly Administration in Children Aged 5 Years and Older
TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has conducted a Phase... Read more.
Kosmos Energy to Host Third Quarter 2025 Results and Webcast on November 03, 2025
DALLAS–(BUSINESS WIRE)–Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its third quarter 2025 results: Earnings Release: Monday,... Read more.
Tosi Expands Global Availability of Advanced Network Traffic Analytics Following U.S. Launch
Native TosiControl capability strengthens unified platform with real-time OT visibility and threat detection. OULU, Finland & IRVING, Texas–(BUSINESS WIRE)–Tosi,... Read more.
Tacton Acquires Variantum and Serenytics to Deliver the Most Complete End-to-End Platform for Complex Manufacturers
CHICAGO & STOCKHOLM–(BUSINESS WIRE)–Tacton, the global leader in CPQ Buyer Engagement solutions for complex manufacturers, announced today the acquisition... Read more.
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at 36 months in Phase I trial participants Secondary clinical efficacy... Read more.
Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer
Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research Organizations... Read more.
MaaT Pharma Announces Positive Second Safety Interim Analysis from DSMB for Phase 2b PHOEBUS Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT
The DSMB conducted an unblinded safety review of data from the first 120 enrolled patients and identified no safety concerns and no excessive mortality related to... Read more.
BitGo Secures VARA Broker-Dealer Licence to Launch Regulated Institutional Trading Services in Dubai
DUBAI, United Arab Emirates–(BUSINESS WIRE)–BitGo MENA FZE (“BitGo MENA”), the digital asset infrastructure company, announced that it has secured... Read more.
US $680 Million Power Move: KEO World and MAHA Capital Unite to Redefine the Economics of Business Credit
MIAMI–(BUSINESS WIRE)–KEO World has signed an agreement to sell its Mexican, Brazilian, Canadian, U.S. credit subsidiaries and the Workeo IPR to MAHA... Read more.